about
Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.Statins in Asthma: Potential Beneficial Effects and LimitationsAntioxidants, inflammation and cardiovascular diseaseInflammation in arterial diseasesVascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitusCell-based screening identifies the active ingredients from Traditional Chinese Medicine formula Shixiao San as the inhibitors of atherosclerotic endothelial dysfunctionLDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesionsStatins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell diseaseThe pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathiesRosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials.Radiation as a risk factor for cardiovascular disease.Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase AktNitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.Reduction in basal nitric oxide activity causes albuminuriaAtorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage.Impact of statin treatment on strut coverage after drug-eluting stent implantation.Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?Hypercholesterolemia impairs exercise capacity in mice.Atorvastatin and prevention of contrast induced nephropathy following coronary angiography.Psychosocial stress and cardiovascular diseases.Abundant pleiotropy in human complex diseases and traits.Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia ratsLIPITENSION: Interplay between dyslipidemia and hypertensionCounting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.Effects of statins on cardiorenal syndrome.Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.Epigenetic upregulation of p66shc mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunctionROCKs as therapeutic targets in cardiovascular diseasesRho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges.The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients.Skeletal muscle ultrastructure and function in statin-tolerant individualsStatins and bone metabolism.The role of statins in reversing atherosclerosis: what the latest regression studies show.Statins: another class of antihypertensive agents?Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial.The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation.Statins and the vascular endothelial inflammatory response
P2860
Q24602803-4F9926BC-C9E3-411D-81F5-064FA69E3AFBQ24815293-188FDF30-4915-41E7-A424-66806D76873FQ26776067-09569726-8287-446D-817A-FDF55EFEB4ADQ26823009-2E70B582-AE53-4718-AB44-29DCACBABBEFQ26853576-F0187D03-78BD-4859-9051-BFB2B29B6F36Q28219328-83122405-4F8A-4C75-93CF-A5E56081D9CBQ28543569-469D1697-BBDA-4FA4-A6B4-3DD1A6FE2951Q30422549-A7802E19-84DC-4785-B61A-8725942AEB15Q30488574-262DADDD-B9A5-4723-B78C-C5A59B07371BQ30492867-13022D00-B69C-424C-B966-FEE036500273Q33350185-D9EC8FA0-DF06-4AFE-A20E-C63F62D20458Q33702090-87DDCEF0-5168-4A63-B739-ED1C8FF343C1Q33857895-A4457434-0E40-4748-ADBF-87F18AF64392Q34150728-2E2E2396-3A7F-4821-85A5-D7B8B1E13B99Q34331352-6892AA0B-92EB-4C86-B329-4B4981453718Q34376402-C8BC08F0-6E41-48F0-9753-AE33482FF391Q34527146-D97627FC-7903-421F-9222-FE3408992FF4Q34669052-0328D071-47BA-4951-92DF-176BB8029008Q34774239-BF5B1F78-65E9-4497-B411-299FAC2F743FQ35047134-CF95C2F6-BF3E-49CF-9853-1FB498167186Q35117350-A42FB8F4-64DB-4CB9-AA11-4CAD10F95AF8Q35160480-1C28E1E5-51F0-471F-B0BA-E5AA51F0FEF6Q35522325-F0B34825-96EC-4226-A48E-7DF5B840AC37Q35542127-D52196A5-E181-410D-8B2D-8C2B8E338C56Q35596105-0A55A779-FF95-4D7D-9A13-D207D7C632F8Q35856063-1510624D-566E-4886-946F-38E0316265E9Q35934133-26A27AE0-B375-48A2-91F7-0337BE91B145Q36077149-24A4435A-06DB-4642-89E2-7DE5D896E2AEQ36088110-519A19D6-EEA8-4CBE-AA99-FAD19DC7F563Q36115533-E932AEF0-AA01-46E1-AA3D-BD2DDAF2F7CEQ36124892-B9142E08-78CA-443F-AC1D-B6B4DC8A184DQ36219699-A262B0AD-66AE-41FD-BBF6-175FBFEBD35FQ36347868-E0AB0D06-6D81-42FC-AFCC-6ED1C6C70E32Q36355588-698E4211-D50C-410D-A30F-3AA3D6399159Q36395695-8FC119A7-26A8-4528-8509-D2D1EB7C5271Q36398720-3A3DCBBD-1135-4591-8198-6B5333C56B43Q36411099-24CF453F-E316-430A-BC81-4A98B4E0A842Q36469959-4531D419-6D47-479F-828C-0BC3647B805DQ36536154-E8EED7C9-A757-45D1-A8F2-B0687A4C9B78Q36695979-85B630E3-C169-45F9-8106-81690FB80289
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Endothelium-dependent effects of statins.
@ast
Endothelium-dependent effects of statins.
@en
type
label
Endothelium-dependent effects of statins.
@ast
Endothelium-dependent effects of statins.
@en
prefLabel
Endothelium-dependent effects of statins.
@ast
Endothelium-dependent effects of statins.
@en
P2093
P1476
Endothelium-dependent effects of statins.
@en
P2093
James K Liao
Kristin S Jensen
Sebastian Wolfrum
P304
P356
10.1161/01.ATV.0000063385.12476.A7
P407
P577
2003-02-27T00:00:00Z